regulatory compliance
| 4 min read
The FDA’s National Priority Voucher program aims to cut standard review times from potentially years to months, raising questions about safety, access, and public health impact.
| 5 min read
A new study finds that non-core and non-essential procedures may add significant burden to participants and research sites.
| 5 min read
Computational models are reshaping how therapies are discovered, tested, and optimized.
| 5 min read
Regulatory science is increasingly relying on modeling, simulation, and AI tools to accelerate drug development while maintaining safety and efficacy.
| 5 min read
A wave of FDA rejections reveals how CMC issues are becoming a leading barrier to approval in cell and gene therapy development.
Available on Demand
Learn about the pathways and strategies to bring medical device innovations to life.
Page 1 of 1 - 6 Total Items
